Browse the corpus

REFERENCES National Asthma Education and Prevention Program (NAEPP), “Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma,” Clinical Practice Guidelines , National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007; available at file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Pedersen S, Warner J, Wahn U, et al, “Growth, Systemic Safety, and Efficacy During 1 Year of Asthma Treatment With Different Beclomethasone Dipropionate Formulations: An Open-Label, Randomized Comparison of Extra Fine and Conventional Aerosols in Children,” Pediatrics , 2002, 109(6), file://www.pediatrics.org/cgi/content/full/109/6/e92. [PubMed 12042586 ] Tinkelman DG, Reed CE, Nelson HS, et al, “Aerosol Beclomethasone Dipropionate Compared With Theophylline as Primary Treatment of Chronic, Mild-to-Moderately Severe Asthma in Children,” Pediatrics , 1993, 92(1):64-77. [PubMed 8516087 ] Wyatt R, Waschek J, Weinberger M, et al, “Effects of Inhaled Beclomethasone Dipropionate and Alternate-Day Prednisone on Pituitary-Adrenal Function in Children With Chronic Asthma,” N Engl J Med , 1978, 299(25):1387-92. [PubMed 362207 ] Topic 15948 Version 29.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1105-88.81.100.162-4217E6CC24-S244013.14]